Trump Pushes Drug Pricing Legislation in 2026
The White House is circulating draft drug pricing legislation to major pharma companies, escalating Trump's push to reshape U.S. medication pricing policy.
Pharmaceutical Policy
3 articles tagged "Pharmaceutical Policy"
Trump Drug Pricing Flaw & Gilead Deal: What to Know
A structural gap in Trump's most-favored nation drug pricing framework raises doubts, while Gilead Sciences makes a major autoimmune therapeutics acquisition.
By Robert Kim
Trump Drug Pricing & GSK Asthma Inhaler Controversy 2026
The White House pushes most-favored-nation drug pricing legislation while a Senate report scrutinizes GSK's asthma inhaler discontinuation strategy.